Jonathan Leiken - 01 Mar 2026 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 19:52:26 UTC
Prior SEC filing
04 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken

Key filing fact

Jonathan Leiken filed Form 4 for DANAHER CORP /DE/ (DHR) on 03 Mar 2026.

Key facts

  • This page summarizes Jonathan Leiken's Form 4 filing for DANAHER CORP /DE/ (DHR).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2026, 19:52.

Change

  • Previous filing in this sequence was filed on 04 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001608984 Primary reporting owner

Leiken Jonathan

Relationship
SVP-Chief Legal Officer
Address
2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON
Signature
/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DHR transaction

Common Stock

Award

Transaction value
$0
Shares
+2,374
Change %
+23%
Price
$0.000000
Shares after
12,546
Date
01 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DHR transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
$0
Shares
+6,416
Change %
Price
$0.000000
Shares after
6,416
Date
01 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,416
Exercise price
$210.64
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. Twenty-five percent of the RSUs vest on each of the first four anniversaries of the grant date, which is March 1, 2026.

Footnote F2

Fifty percent of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .